Philadelphia, PANCT06080698Now EnrollingIRB Ready

Gram-negative Bacteremia Clinical Trial in Philadelphia, PA

Access cutting-edge gram-negative bacteremia treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by Johns Hopkins University

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access gram-negative bacteremia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related gram-negative bacteremia treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this gram-negative bacteremia clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Gram-negative Bacteremia Study in Philadelphia

The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective but safer than remaining on intravenous (IV) antibiotic therapy for the duration of treatment.

Sponsor: Johns Hopkins University

Who Can Participate

Inclusion Criteria

Adult (≥ 18 years) at the time of screening
Hospitalized
Identification of at least one Gram-negative organism in a blood culture
Capable of providing written informed consent (includes through a legally authorized representative)
Willingness to adhere to assigned study arm
Capable and willing to complete a follow-up QoL interview (including through a legally authorized representative)

Exclusion Criteria

Unable to tolerate or absorb a course of oral antibiotics
Actively receiving vasopressors
Gram-negative organism not susceptible to any oral antibiotics
Gram-negative organism not susceptible to any IV antibiotics
Polymicrobial bloodstream infection
The following patients with polymicrobial infections remain eligible for enrollment: (1) more than one morphology or species of a gram-negative organism (except for Acinetobacter baumannii or Stenotrophomonas maltophilia), (2) a single positive blood culture with a common commensal organism (grown in addition to an Enterobacterales species or Pseudomonas aeruginosa
Allergy or contraindication rendering no oral option or no IV option for therapy with the listed antibiotic agents.
Anticipated duration of therapy greater than 14 days
Central nervous system infection
Absolute neutrophil count of \<500 cells/mL or anticipated to reduce to \<500 cells/mL during the antibiotic treatment course.
Receiving hospice care

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT06080698) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gram-negative Bacteremia Treatment Options in Philadelphia, PA

If you're searching for gram-negative bacteremia treatment options in Philadelphia, PA, this clinical trial (NCT06080698) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gram-negative bacteremia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gram-negative bacteremia clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Philadelphia, PA

See all heart attack clinical trials recruiting in Philadelphia — not just this study.

Browse Heart Attack Trials in Philadelphia →

Browse More Trials by Condition

Heart Attack TrialsRheumatoid Arthritis TrialsGeographic Atrophy TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA